Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
   By Ben Fox Rubin 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at

Subscribe to WSJ:

Recommend :
React to this article
Latest news on JOHNSON & JOHNSON
3h ago NOVARTIS : Sotax to introduce new equipment in india
3h ago JOHNSON & JOHNSON : J&J builds world's largest supply chain base
5h ago JOHNSON & JOHNSON : QMED -Irish Eyes Are Smiling at New Ethicon Plant in Limeric..
1d ago JOHNSON & JOHNSON : J&J builds world's largest supply chain base
1d agoDJEuropean Regulator Warns of More Drug Tampering
1d ago JOHNSON & JOHNSON : QMED -JNJ Beats Estimates, Device Sales Flat
1d ago GSK, facing bribery claims, battles to build new sales model
2d ago JOHNSON & JOHNSON : New Serum Globulins Data Have Been Reported by Researchers a..
2d ago JOHNSON & JOHNSON : Researchers from Johnson & Johnson Report Details of New Stu..
2d ago JOHNSON & JOHNSON : The Makers Of PEPCID® Partner With Ted Allen And Eater.Com T..
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
Johnson _ Johnson : Income Statement Evolution
More Financials
Dynamic quotes